Early behavioural effects of intraventricular administration of 6-hydroxydopamine in rat.
D000818:Animals; D001522:Behavior, Animal / Q000187:drug effects*; D002421:Caudate Nucleus / Q000201:enzymology; D002552:Cerebral Ventricles; D003342:Corpus Striatum / Q000378:metabolism; D003864:Depression, Chemical; D004298:Dopamine / Q000494:pharmacology*; D006120:Grooming / Q000187:drug effects; D006624:Hippocampus / Q000201:enzymology; D007031:Hypothalamus / Q000201:enzymology; D008297:Male; D008636:Mesencephalon / Q000201:enzymology; D008781:Methyltyrosines / Q000494:pharmacology; D009043:Motor Activity / Q000187:drug effects*; D010293:Pargyline / Q000494:pharmacology*; D010627:Phenethylamines / Q000494:pharmacology*; D051381:Rats; D012110:Reserpine / Q000494:pharmacology; D013378:Substantia Nigra / Q000502:physiology; D014446:Tyrosine 3-Monooxygenase / Q000037:antagonists & inhibitors / Q000378:metabolism
D008781:Methyltyrosines; D010627:Phenethylamines; D012110:Reserpine; D010293:Pargyline; D014446:Tyrosine 3-Monooxygenase; D004298:Dopamine